Safety of thrombolysis in cerebral venous thrombosis: A systematic review of the literature

Thrombosis and Haemostasis

Volumn 104, Issue 5, 2010, Pages 1055-1062

  Dentali, Francesco ^a   Squizzato, Alessandro ^a   Gianni, Monica ^b   De Lodovici, Maria L ^a   Venco, Achille ^a   Paciaroni, Maurizio ^c   Crowther, Mark ^d   Ageno, Walter ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Hospital of Tradate   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Cerebral vein thrombosis; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; EMBASE; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; MORTALITY; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; INTRACRANIAL HEMORRHAGES; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 78149473739     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-05-0311     Document Type: Article

References (22)

1. Dentali F, Gianni M, Crowther MA, et al. Natural history of cerebral vein thrombosis: a systematic review. Blood 2006; 108: 1129-1134.
2. Ferro JM, Canhão P, Stam J, et al; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670.
3. Einhäupl K, Stam J, Bousser MG, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010; epub ahead of print.
4. Smith TP, Higashida RT, Barnwell SL, et al. Treatment of dural sinus thrombosis by urokinase infusion. AJNR Am J Neuroradiol 1994; 15: 801-807.
5. McGinn T, Wyer PC, Newman TB, et al for Evidence-Based Medicine Teaching Tips Working Group.Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004; 171: 1369-1373.
6. Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694.
7. Stam J, Majoie CB, van Delden OM, et al. Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study. Stroke 2008; 39: 1487-1490.
8. Zhang A, Collinson RL, Hurst RW, et al. Rheolytic thrombectomy for cerebral sinus thrombosis. Neurocrit Care 2008; 9: 17-26.
9. Tsai FY, Kostanian V, Rivera M, et al. Cerebral venous congestion as indication for thrombolytic treatment. Cardiovasc Intervent Radiol 2007; 30: 675-687.
10. Soleau SW, Schmidt R, Stevens S, et al. Extensive experience with dural sinus thrombosis. Neurosurgery 2003; 52: 534-544
11. Wasay M, Bakshi R, Kojan S, et al. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke 2001; 32: 2310-2317.
12. Baker MD, Opatowsky MJ, Wilson JA, et al. Rheolytic catheter and thrombolysis of dural venous sinus thrombosis: a case series. Neurosurgery 2001; 48: 487-493.
13. Philips MF, Bagley LJ, Sinson GP, et al. Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 1999; 90: 65-71.
14. Frey JL, Muro GJ, McDougall CG, et al. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke 1999; 30: 489-494.
15. Kim SY, Suh JH. Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase. AJNR Am J Neuroradiol 1997; 18: 639-645.
16. Tsai FY, Wang AM, Matovich VB, et al . MR staging of acute dural sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol 1995; 16: 1021-1029.
17. Horowitz M, Purdy P, Unwin H, et al. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol 1995; 38: 58-67.
18. Barnwell SL, Nesbit GM, Clark WM. Local thrombolytic therapy for cerebrovascular disease: current Oregon Health Sciences University experience (July 1991 through April 1995). J Vasc Interv Radiol 1995; 6 (Suppl): 78S-82S.
19. Di Rocco C, Iannelli A, Leone G, et al. Heparin-urokinase treatment in aseptic dural sinus thrombosis. Arch Neurol 1981; 38: 431-435.
20. Jaillon-Riviere V, Courthéoux P, Defer GL. Place of local thrombolytic therapy in the treatment for cerebral venous thrombosis. Rev Neurol 2009; 165: 916-923.
21. Canhão P, Falcão F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 2003; 15: 159-166.
22. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-560.